Similarly, CDC20 overexpression decreased the percentage of annexin V-positive and PI-negative cells (Fig. 6a) and the enzymatic activities of caspase-3/7 (Fig. 6b) in glioma cells treated with compound 331 (20 μM, 48 h). The gene discussed is CDC20; the disease is central nervous system cancer.